About US
Contact us
-
Novo Nordisk tapped Thermo Fisher to help make obesity drug Wegovy amid Catalent woes: ReutersNovo Nordisk is struggling to meet strongdemand forWegovy, and the company has reportedly tapped another contract manufacturer to churn out the popular weight-loss drug.2023/8/21
-
PHARMA In GSK's trial of shingles vaccine in China, Shingrix keeps it 100In October of last year, GSK laid out a plan todoubleits business in China by 2025, with much of that expansion dependent upon the success of Shingrix, the company’s recombinant zoster vaccine (RZV)2023/8/21
-
Apellis flags needle problems in hunt for Syfovre side effect sourceWhile nothing is certain yet, Apellis may be homing in on the source of a rare but serious side effect tied to its world-first geographic atrophy drug Syfovre. The safety update comes as the company2023/8/18
-
With new lawsuit, Boehringer Ingelheim becomes latest drugmaker to take aim at IRAAs litigation challenging the Inflation Reduction Act (IRA) piles up, Boehringer Ingelheim has become the latest drugmaker to take aim at the new law. In a 62-page lawsuit, Boehringer lai2023/8/18
-
Novartis to lay off another 100-plus employees at US HQ as global restructuring rolls onAfter cutting hundreds of jobs in New Jersey around the start of this year, Novartis is at it again. Novartis plans to lay off 103 employees at its its U.S. headquarters in East Hanover,2023/8/14
-
Spanish drugmaker Serra Pamies suffers manufacturing clampdown by EMAProblems with quality management, data integrity, expired raw materials and more have prompted the European Medicines Agency (EMA) to put the kibosh on manufacturing at Serra Pamies’ Reus, Spain, fac2023/8/14
-
Teva, Glenmark reach $255M price-fixing settlement with DOJ, agree to offload certain medsAfter admitting to running a price-fixing scheme as part of a deal with the Department of Justice, not only will generic makers Teva and Glenmark Pharmaceuticals pay hefty fines, but they'll also be2023/8/11
-
Pfizer's Abrysvo becomes first maternal RSV shot to protect newbornsAlready with an approval in hand for older adults, Pfizer’s Abrysvo has become the first vaccine for pregnant women to protect their newborns against respiratory syncytial virus (RSV). Th2023/8/11
-
What infeasible trial? Lilly shows Roche how it's done with positive Retevmo readout in thyroid cancerIt was only a few weeks ago when Roche said a phase 3 study testing its RET inhibitor Gavreto in a type of thyroid cancer was not doable. Now, Eli Lilly has revealed that a similar trial of its own R2023/8/7
-
Roche, Exelixis' Tecentriq-Cabometyx combo rebounds with partial win in previously treated prostate cancerAfter a losing streak in the clinic, Roche and Exelixis’ combo of Tecentriq and Cabometyx has delivered a trial win in tough-to-treat prostate cancer. Roche’s immuno-oncology star Tecentr2023/8/7